BiP (HSPA5) is a 78-kDa member of the heat shock protein 70 (HSP70) family, primarily localized in the endoplasmic reticulum (ER). It functions as a molecular chaperone, assisting in protein folding, calcium homeostasis, and stress response . Anti-BiP antibodies target this protein and are implicated in autoimmune diseases like rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) .
A meta-analysis of nine studies (1995–2016) revealed:
| Parameter | Pooled Value (95% CI) |
|---|---|
| Sensitivity | 0.67 (0.64–0.70) |
| Specificity | 0.92 (0.90–0.93) |
| Positive Likelihood Ratio (LR+) | 7.65 (4.08–14.36) |
| Negative Likelihood Ratio (LR−) | 0.36 (0.33–0.39) |
| Diagnostic Odds Ratio (DOR) | 23.73 (13.01–43.28) |
Anti-BiP antibodies demonstrate moderate sensitivity but high specificity for RA diagnosis, making them a complementary biomarker to rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPAs) .
Pre-disease Detection: Found in sera up to 4.7 years before RA symptom onset (sensitivity: 45%; specificity: 65%) .
Citrullinated BiP (citBiP): A subset of anti-BiP antibodies targets citrullinated BiP, correlating with anti-CCP antibody levels (R² = 0.41) .
Pathogenic Role: CitBiP immunization exacerbates collagen-induced arthritis (CIA) in mice and induces ACPA production .
Immune Modulation: Native BiP administration promotes IL-4/IL-10-producing CD4⁺ T cells, suppressing inflammation in murine arthritis models .
| Biomarker | Sensitivity | Specificity | Clinical Utility |
|---|---|---|---|
| Anti-BiP | 67% | 92% | High specificity for RA |
| RF | 60–70% | 75–85% | Lower specificity |
| Anti-CCP | 60–70% | 95% | Gold standard for RA diagnosis |
Anti-BiP antibodies are less sensitive than RF and anti-CCP but offer superior specificity .
ER Stress Link: BiP overexpression occurs during ER stress, common in RA synovial cells .
Drug Target: BiP inhibition reduces estrogen-dependent cell growth and viability in vitro, suggesting therapeutic applications .
STRING: 39947.LOC_Os08g09770.1
BIP5 (Luminal-binding protein 5) is a member of the BiP family of proteins that plays a crucial role in facilitating the assembly of multimeric protein complexes inside the endoplasmic reticulum (ER) . As a member of the 78 kDa glucose-regulated protein family (also known as GRP-78-5), it functions as a molecular chaperone involved in protein folding and quality control in the ER. BiP proteins are highly conserved across species and have been studied extensively for their roles in the unfolded protein response (UPR) and ER stress pathways, though BIP5 specifically has been characterized in Nicotiana tabacum (tobacco plant) .
The BIP5 antibody has been validated for Western blotting (WB), immunofluorescence (IF), and immunoprecipitation (IP) . These techniques allow researchers to detect, visualize, and isolate BIP5 from biological samples for various research purposes. Each application requires specific optimization for sample preparation, antibody concentration, and detection methods to achieve reliable results.
The BIP5 antibody should be stored at -20°C where it remains stable for approximately 12 months from the date of receipt . Proper storage is crucial for maintaining antibody functionality and preventing degradation. For working solutions, it is generally recommended to prepare single-use aliquots to avoid repeated freeze-thaw cycles, although this specific recommendation is not explicitly stated in the available information for this particular antibody.
BIP5 (Luminal-binding protein 5) is part of the larger BiP family of proteins that function as molecular chaperones in the endoplasmic reticulum. While the available information focuses specifically on BIP5 found in Nicotiana tabacum , it's worth noting that BiP proteins are highly conserved across species. In humans, BiP (immunoglobulin binding protein) has been implicated in various diseases, including rheumatoid arthritis, where it can stimulate synovial T-cell proliferation . The relationship between plant BIP5 and human BiP proteins represents an interesting area for comparative studies, though they have distinct contexts of investigation.
For optimal Western blotting results with BIP5 antibody, researchers should consider several critical parameters. Based on general principles for monoclonal antibodies like BIP5 , the following protocol is recommended:
Sample preparation: Extract proteins using a buffer containing protease inhibitors to prevent degradation.
Gel electrophoresis: Use an appropriate percentage SDS-PAGE gel (typically 10-12% for proteins around 78kDa like BIP5).
Transfer conditions: Optimize transfer time and voltage based on protein size (recommended: 100V for 1 hour or 30V overnight for large proteins).
Blocking: Use 5% non-fat dry milk or BSA in TBST for 1 hour at room temperature.
Primary antibody incubation: Dilute BIP5 antibody (typically 1:1000 to 1:2000, though optimal dilution should be determined experimentally) in blocking buffer and incubate overnight at 4°C.
Secondary antibody: Use an appropriate HRP-conjugated anti-mouse secondary antibody (as BIP5 antibody originates from mouse ) at a 1:5000 dilution.
Detection: Use ECL substrate appropriate for the expected expression level of BIP5.
The expected molecular weight for BIP5 is approximately 78 kDa, consistent with its alternative name as 78 kDa glucose-regulated protein homolog 5 .
While the BIP5 antibody has confirmed reactivity with Nicotiana tabacum , researchers interested in cross-reactivity testing with other plant species should implement a systematic validation approach:
Sequence homology analysis: Perform bioinformatic analysis to identify homologous BiP5 proteins in target species, focusing on epitope conservation.
Gradient testing: Test antibody recognition across multiple species using a consistent protein extraction protocol.
Validation methods: Employ multiple techniques (Western blot, immunoprecipitation, and immunofluorescence) to confirm specificity.
Controls: Include positive controls (Nicotiana tabacum extracts) and negative controls (species without BiP5 homologs).
Epitope competition assays: If specific epitopes are known, peptide competition assays can confirm binding specificity.
Table 1: Hypothetical cross-reactivity testing of BIP5 antibody across plant species
Note: This table contains hypothetical data based on typical cross-reactivity patterns of plant antibodies and should be experimentally verified.
When performing immunofluorescence with BIP5 antibody, researchers should consider:
Fixation method: Different fixatives (paraformaldehyde, methanol, acetone) can affect epitope accessibility. For ER-resident proteins like BIP5, 4% paraformaldehyde followed by permeabilization with 0.1% Triton X-100 is often effective.
Antibody concentration: Titrate the BIP5 antibody to determine optimal concentration (typically starting at 1:100-1:500 for IF applications).
Co-localization markers: Include established ER markers (e.g., calnexin, PDI) to confirm BIP5's ER localization.
Counterstaining: Use DAPI for nuclear visualization and appropriate plant cell wall stains if working with intact plant tissues.
Controls:
Positive control: Tissues known to express high levels of BIP5
Negative control: Tissues lacking BIP5 expression
Secondary antibody-only control: To assess background fluorescence
Image acquisition parameters: Use consistent exposure settings for quantitative comparisons, and acquire z-stacks for 3D reconstruction of ER distribution.
Stress response studies: Consider comparing BIP5 localization under normal and stress conditions, as BiP proteins are often upregulated during ER stress.
Distinguishing BIP5 from other BiP family members requires careful methodological considerations:
Specificity verification: Verify the epitope recognized by the BIP5 antibody through epitope mapping or manufacturer specifications to ensure it targets a region unique to BIP5.
Pre-absorption controls: If cross-reactivity is a concern, pre-absorb the antibody with recombinant proteins of other BiP family members before use.
Knockout/knockdown validation: When possible, use genetic approaches (CRISPR, RNAi) to create BIP5-deficient samples as negative controls.
Comparative analysis: When studying multiple BiP family members, design experiments that directly compare recognition patterns using antibodies specific to each family member.
Mass spectrometry validation: For critical experiments, confirm Western blot or IP results with mass spectrometry identification of the detected/pulled-down proteins.
Table 2: Hypothetical distinction profile between BiP family members in tobacco
| Technique | Distinguishing Features | Potential Challenges | Recommended Controls |
|---|---|---|---|
| Western Blot | Slight MW differences between BiP isoforms | Limited resolution of similar-sized proteins | Include recombinant BiP standards |
| IP-MS | Direct protein identification by peptide sequencing | Requires high-quality samples | Include isotype control antibody |
| RT-qPCR | Distinguishes at mRNA level | Not a direct measure of protein | Include all BiP family primers |
| IF co-localization | Potential differential subcellular localization | Resolution limitations | Include markers for various ER subdomains |
To optimize immunoprecipitation with BIP5 antibody, researchers should consider:
Lysis buffer optimization:
For membrane-associated ER proteins like BIP5, use buffers containing 1% NP-40 or Triton X-100
Include protease inhibitors to prevent degradation
Consider adding phosphatase inhibitors if studying post-translational modifications
Pre-clearing step:
Pre-clear lysates with protein A/G beads to reduce non-specific binding
Perform at 4°C for 1 hour with gentle rotation
Antibody incubation:
Determine optimal antibody amount (typically 2-5 μg per mg of protein lysate)
Incubate overnight at 4°C with gentle rotation
Washing conditions:
Use increasingly stringent washes to reduce background
Typical wash buffers include:
a) Lysis buffer (2 washes)
b) Lysis buffer with 500 mM NaCl (1 wash)
c) Final wash in TBS or PBS (1 wash)
Elution strategies:
Harsh elution: SDS sample buffer at 95°C (denatures proteins)
Mild elution: Antigenic peptide competition (preserves protein complexes)
Controls:
Input control: 5-10% of pre-IP lysate
IgG control: Matched isotype control antibody
Beads-only control: To assess non-specific binding to beads
BiP family proteins typically respond to ER stress conditions as part of the unfolded protein response. While specific data for BIP5 in tobacco isn't provided in the search results, researchers can implement the following methodology to study stress-induced changes:
Stress induction protocols:
Chemical stressors: Tunicamycin (N-glycosylation inhibitor), DTT (reducing agent), thapsigargin (SERCA inhibitor)
Environmental stressors: Heat shock, cold stress, drought, salinity
Duration: Time course experiments (1h, 3h, 6h, 12h, 24h)
Quantification methods:
Analysis approaches:
Normalize expression to appropriate housekeeping genes/proteins
Calculate fold-change relative to unstressed conditions
Statistical testing to determine significance of observed changes
Table 3: Hypothetical BIP5 expression changes under different stress conditions
| Stress Condition | Duration | Protein Level Change (Fold) | mRNA Level Change (Fold) | Subcellular Redistribution |
|---|---|---|---|---|
| Control | - | 1.0 | 1.0 | Diffuse ER pattern |
| Tunicamycin (5 μg/ml) | 6h | 3.2 ± 0.4 | 5.7 ± 0.6 | Enhanced perinuclear accumulation |
| Heat shock (42°C) | 2h | 2.5 ± 0.3 | 4.1 ± 0.5 | Punctate ER pattern |
| Drought simulation | 24h | 1.8 ± 0.2 | 2.3 ± 0.3 | Minimal change |
| Salt stress (150 mM NaCl) | 12h | 2.1 ± 0.3 | 3.2 ± 0.4 | ER expansion observed |
Note: This table contains hypothetical data based on typical stress responses of BiP proteins and would need experimental verification for BIP5 specifically.
When working with BIP5 antibody in Western blotting, researchers may encounter several issues:
Weak or no signal:
Increase antibody concentration or incubation time
Verify protein loading (increase if necessary)
Check transfer efficiency with Ponceau S staining
Consider more sensitive detection systems (ECL Plus or Femto)
Verify sample preparation maintains protein integrity
Ensure the antibody hasn't degraded due to improper storage
Multiple bands or high background:
Increase blocking time/concentration
Dilute primary antibody further
Add 0.1-0.5% Tween-20 to antibody dilution buffer
Increase washing frequency and duration
Consider using different blocking agent (switch between milk and BSA)
Check for cross-reactivity with similar BiP family members
Unexpected band size:
Verify using positive control sample
Check for post-translational modifications
Confirm protein extraction method preserves full-length protein
Consider native vs. reducing conditions
Sample-specific issues:
For plant samples, increase extraction buffer stringency to overcome cell wall interference
Consider tissue-specific extraction protocols
For heavily glycosylated samples, consider deglycosylation treatments
To develop reliable quantitative assays for BIP5 measurement:
Western blot densitometry:
Use a dilution series of recombinant BIP5 to create a standard curve
Process all samples under identical conditions
Use fluorescent secondary antibodies for wider linear range of detection
Normalize to multiple housekeeping proteins for accuracy
Analyze using ImageJ or similar software with appropriate background subtraction
ELISA development:
Coat plates with capture antibody (anti-BIP5 or conformation-specific antibody)
Use BIP5 antibody as detection antibody (may require biotinylation)
Develop standard curves using recombinant BIP5 protein
Validate assay parameters (specificity, sensitivity, reproducibility)
Flow cytometry for protoplasts:
Optimize protoplast isolation from plant tissues
Permeabilize and stain with fluorescently-labeled BIP5 antibody
Include appropriate controls for autofluorescence
Gate on specific cell populations if studying tissue heterogeneity
Mass spectrometry-based approaches:
Develop MRM (Multiple Reaction Monitoring) assays for targeted BIP5 quantification
Use isotopically-labeled peptide standards for absolute quantification
Focus on unique peptides that distinguish BIP5 from other BiP family members
When studying stress response pathways with BIP5 antibody, researchers should consider:
Experimental design aspects:
Include appropriate time-course sampling (early and late responses)
Combine multiple stressors to assess pathway interactions
Include both acute and chronic stress exposures
Consider tissue-specific responses (roots vs. leaves)
Technical considerations:
Ensure stress conditions don't interfere with antibody-epitope interactions
Process all samples simultaneously to minimize batch effects
Include sample harvesting controls to account for handling-induced stress
Verify antibody performance under experimental conditions
Complementary approaches:
Combine with transcriptomic analysis to correlate protein and mRNA changes
Use pharmacological inhibitors to dissect pathway components
Consider genetic approaches (knockout/knockdown) to establish causality
Data interpretation:
Distinguish between direct and indirect effects on BIP5 expression
Consider post-translational modifications that may affect antibody recognition
Evaluate changes in BIP5 interactions with other proteins during stress
The BIP5 antibody, with its specificity for Nicotiana tabacum BiP5 , can serve as a valuable tool for evolutionary studies of stress response mechanisms:
Comparative immunoblotting across species:
Test cross-reactivity with BiP homologs in diverse plant species
Compare molecular weights and expression patterns
Identify conserved and divergent aspects of BiP regulation
Epitope conservation analysis:
Map the specific epitope recognized by the BIP5 antibody
Analyze epitope conservation across plant lineages
Correlate epitope conservation with functional conservation
Stress response profiling:
Compare stress-induced changes in BiP expression across species
Identify conserved stress response signatures
Link differences to ecological adaptations
Co-immunoprecipitation studies:
Identify interacting partners across species
Compare protein complex composition
Assess conservation of BiP-mediated pathways
This approach could provide insights into how ER stress response mechanisms evolved across plant lineages and identify core conserved elements versus lineage-specific adaptations.
While the search results don't specifically address BIP5's role in immunity, BiP proteins have been implicated in immune responses in other systems. Researchers could explore:
Pathogen challenge experiments:
Monitor BIP5 expression changes during pathogen infection
Compare responses to bacterial, viral, and fungal pathogens
Assess differences between compatible and incompatible interactions
Subcellular dynamics:
Functional studies:
Overexpress or silence BIP5 and assess impact on pathogen susceptibility
Test if BIP5 directly interacts with pathogen effectors
Investigate BIP5's role in secretory pathway regulation during immune responses
Understanding BIP5's potential role in plant immunity could provide new insights into how ER function and protein quality control intersect with defense responses.